Benvenue Medical is hosting a satellite symposium entitled “Clinical evidence in the treatment of vertebral compression fractures: Kiva system” at the upcoming annual meeting of the Cardiovascular and Interventional Radiological Society of Europe (CIRSE; 14–18 September, Barcelona, Spain) on 16 September.
The symposium will review the company’s Kiva system for the treatment of vertebral compression fractures (VCF). It will feature a distinguished panel of physicians who will present clinical outcomes of the Kiva VCF treatment system. According to a press release, three of the studies being presented are a direct comparison of Kiva versus balloon-assisted vertebral augmentation in treating VCFs. It reports that one or more of the studies showed the Kiva system demonstrated improvement over balloon-assisted vertebral augmentation in reducing new fractures, correcting kyphosis, reducing implanted PMMA volume or reducing extravasation rates. The studies also confirmed that Kiva performs similarly to balloon-assisted vertebral augmentation in safety, reducing pain and restoring function.
The symposium will be moderated by Sean M Tutton, professor of Radiology and Surgery at the Medical College of Wisconsin in Milwaukee, Wisconsin, USA.
“We’re excited about the breadth and depth of clinical evidence demonstrating Kiva’s performance in treating different types of VCFs from osteoporosis, cancer and trauma, especially now that our 510(k) is pending,” said Robert K. Weigle, chief executive officer of Benvenue Medical.